Search

Your search keyword '"Anazodo, Antoinette"' showing total 523 results
Start Over Author "Anazodo, Antoinette"
523 results on '"Anazodo, Antoinette"'

3. Fatal Human Neurologic Infection Caused by Pigeon Avian Paramyxovirus-1, Australia

Author

Hurley, Siobhan, Eden, John Sebastian, Bingham, John, Rodriguez, Michael, Neave, Matthew J., Johnson, Alexandra, Howard-Jones, Annaleise R., Kok, Jen, Anazodo, Antoinette, McMullan, Brendan, Williams, David T., Watson, James, Solinas, Annalisa, Kim, Ki Wook, and Rawlinson, William

Subjects
Nervous system diseases, Conjunctivitis, B cells, Health
Abstract

Newcastle disease is a common and highly contagious zoonotic infection affecting wild and domestic birds globally; it is caused by virulent strains of avian paramyxovirus type 1 (APMV-1) (1,2). APMV-1 [...]

Published
2023
Full Text
View/download PDF

6. A View from the past into our collective future: the oncofertility consortium vision statement.

Author

Woodruff, Teresa K, Ataman-Millhouse, Lauren, Acharya, Kelly S, Almeida-Santos, Teresa, Anazodo, Antoinette, Anderson, Richard A, Appiah, Leslie, Bader, Joy, Becktell, Kerri, Brannigan, Robert E, Breech, Lesley, Bourlon, Maria T, Bumbuliene, Žana, Burns, Karen, Campo-Engelstein, Lisa, Campos, Jacira R, Centola, Grace M, Chehin, Mauricio Barbour, Chen, Diane, De Vos, Michel, Duncan, Francesca E, El-Damen, Ahmed, Fair, Douglas, Famuyiwa, Yemi, Fechner, Patricia Y, Fontoura, Paula, Frias, Olivia, Gerkowicz, Sabrina A, Ginsberg, Jill, Gracia, Clarisa R, Goldman, Kara, Gomez-Lobo, Veronica, Hazelrigg, Brent, Hsieh, Michael H, Hoyos, Luis R, Hoyos-Martinez, Alfonso, Jach, Robert, Jassem, Jacek, Javed, Murid, Jayasinghe, Yasmin, Jeelani, Roohi, Jeruss, Jacqueline S, Kaul-Mahajan, Nalini, Keim-Malpass, Jessica, Ketterl, Tyler G, Khrouf, Mohamed, Kimelman, Dana, Kusuhara, Atsuko, Kutteh, William H, Laronda, Monica M, Lee, Jung Ryeol, Lehmann, Vicky, Letourneau, Joseph M, McGinnis, Lynda K, McMahon, Eileen, Meacham, Lillian R, Mijangos, Monserrat Fabiola Velez, Moravek, Molly, Nahata, Leena, Ogweno, George Moses, Orwig, Kyle E, Pavone, Mary Ellen, Peccatori, Fedro Alessandro, Pesce, Romina Ileana, Pulaski, Hanna, Quinn, Gwendolyn, Quintana, Ramiro, Quintana, Tomas, de Carvalho, Bruno Ramalho, Ramsey-Goldman, Rosalind, Reinecke, Joyce, Reis, Fernando M, Rios, Julie, Rhoton-Vlasak, Alice S, Rodriguez-Wallberg, Kenny A, Roeca, Cassandra, Rotz, Seth J, Rowell, Erin, Salama, Mahmoud, Saraf, Amanda J, Scarella, Anibal, Schafer-Kalkhoff, Tara, Schmidt, Deb, Senapati, Suneeta, Shah, Divya, Shikanov, Ariella, Shnorhavorian, Margarett, Skiles, Jodi L, Smith, James F, Smith, Kristin, Sobral, Fabio, Stimpert, Kyle, Su, H Irene, Sugimoto, Kouhei, Suzuki, Nao, Thakur, Mili, Victorson, David, Viale, Luz, Vitek, Wendy, and Wallace, W Hamish

Subjects
Fertility preservation, Oncofertility, cancer, Genetics, Paediatrics and Reproductive Medicine, Obstetrics & Reproductive Medicine
Abstract

PurposeToday, male and female adult and pediatric cancer patients, individuals transitioning between gender identities, and other individuals facing health extending but fertility limiting treatments can look forward to a fertile future. This is, in part, due to the work of members associated with the Oncofertility Consortium.MethodsThe Oncofertility Consortium is an international, interdisciplinary initiative originally designed to explore the urgent unmet need associated with the reproductive future of cancer survivors. As the strategies for fertility management were invented, developed or applied, the individuals for who the program offered hope, similarly expanded. As a community of practice, Consortium participants share information in an open and rapid manner to addresses the complex health care and quality-of-life issues of cancer, transgender and other patients. To ensure that the organization remains contemporary to the needs of the community, the field designed a fully inclusive mechanism for strategic planning and here present the findings of this process.ResultsThis interprofessional network of medical specialists, scientists, and scholars in the law, medical ethics, religious studies and other disciplines associated with human interventions, explore the relationships between health, disease, survivorship, treatment, gender and reproductive longevity.ConclusionThe goals are to continually integrate the best science in the service of the needs of patients and build a community of care that is ready for the challenges of the field in the future.

Published
2021

8. Erasure of identity or gender euphoria

Author

Ussher, Jane M., primary, Power, Rosalie, additional, Allison, Kimberley, additional, Sperring, Samantha, additional, Parton, Chloe, additional, Perz, Janette, additional, Davies, Cristyn, additional, Hawkey, Alexandra J., additional, Robinson, Kerry H., additional, Hickey, Martha, additional, Anazodo, Antoinette, additional, Ellis, Colin, additional, and Cook, Teddy, additional

Published
2022
Full Text
View/download PDF

9. Adult medulloblastoma in an Australian population

Author

Parakh, Sagun, Davies, Amy, Westcott, Kerryn, Roos, Daniel, Abou-Hamden, Amal, Ahern, Elizabeth, Lau, Peter K.H., Cheruvu, Sowmya, Pranavan, Ganesalingam, Pullar, Andrew, Lynam, James, Gzell, Cecelia, Whittle, James R., Cain, Sarah, Inglis, Po-ling, Harrup, Rosemary, Anazodo, Antoinette, Hovey, Elizabeth, Cher, Lawrence, and Gan, Hui K.

Published
2022
Full Text
View/download PDF

10. Attitudes, knowledge and practice behaviours of oncology health care professionals towards lesbian, gay, bisexual, transgender, queer and intersex (LGBTQI) patients and their carers: A mixed-methods study

Author

Ussher, Jane M., Perz, Janette, Allison, Kimberley, Power, Rosalie, Hawkey, Alexandra, Dowsett, Gary W., Hickey, Martha, Parton, Chloe, McDonald, Fiona E.J., Davis, Ian D., Quinn, Gwendolyn P., Boydell, Katherine, Robinson, Kerry H., Chambers, Suzanne, and Anazodo, Antoinette

Published
2022
Full Text
View/download PDF

11. Social Anxiety Symptoms in Adolescents and Young Adults Recently Diagnosed with Cancer

Author

Schilstra, Clarissa E., primary, Sansom-Daly, Ursula M., additional, Ellis, Sarah J., additional, Anazodo, Antoinette C., additional, Trahair, Toby N., additional, Lindsay, Toni, additional, Amiruddin, Azhani, additional, O'Dwyer, Cath, additional, Maguire, Fiona, additional, Nevin, Suzanne, additional, Battisti, Robert, additional, and Fardell, Joanna E., additional

Published
2024
Full Text
View/download PDF

13. An MRD-stratified pediatric protocol is as deliverable in adolescents and young adults as in children with ALL

Author

Greenwood, Matthew, Trahair, Toby, Sutton, Rosemary, Osborn, Michael, Kwan, John, Mapp, Sally, Howman, Rebecca, Anazodo, Antoinette, Wylie, Brenton, D'Rozario, James, Hertzberg, Mark, Irving, Ian, Yeung, David, Coyle, Luke, Jager, Amanda, Engeler, Dan, Venn, Nicola, Frampton, Chris, Wei, Andrew H., Bradstock, Kenneth, and Dalla-Pozza, Luciano

Published
2021
Full Text
View/download PDF

14. Communication and ethical considerations for fertility preservation for patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group

Author

Anderson, Richard A, Barnbrock, Anke, Beck, Joern D, Bos, Annelies M E, Calaminus, Gabriele, Constine, Louis S, Demeestere, Isabelle, Denzer, Christian, Grabow, Desiree, di Iorgi, Natascia, Hoefgen, Holly R, Jahnukainen, Kirsi, Kaatsch, Peter, Kebudi, Rejin, Lambalk, Cornelis, Langer, Thorsten, Loonen, Jacqueline, Lorenzo, Armando, Meacham, Lillian R, Meissner, Andreas, Mitchell, Rod T, Nahata, Leena, Ranft, Andreas, Dinkelman-Smit, Marij, Stern, Catharyn, Stutz-Grunder, Eveline, Tournaye, Herman, van Dorp, Wendy, van Pelt, Ans M M, de Vries, Andrica, Yu, Richard, Mulder, Renée L, Font-Gonzalez, Anna, van Dulmen-den Broeder, Eline, Quinn, Gwendolyn P, Ginsberg, Jill P, Loeffen, Erik A H, Hudson, Melissa M, Burns, Karen C, van Santen, Hanneke M, Berger, Claire, Diesch, Tamara, Dirksen, Uta, Giwercman, Aleksander, Gracia, Clarisa, Hunter, Sarah E, Kelvin, Joanne F, Klosky, James L, Laven, Joop S E, Lockart, Barbara A, Neggers, Sebastian J C M M, Peate, Michelle, Phillips, Bob, Reed, Damon R, Tinner, Eva Maria E, Byrne, Julianne, Veening, Margreet, van de Berg, Marleen, Verhaak, Chris M, Anazodo, Antoinette, Rodriguez-Wallberg, Kenny, van den Heuvel-Eibrink, Marry M, Asogwa, Ogechukwu A, Brownsdon, Alexandra, Wallace, W Hamish, Green, Daniel M, Skinner, Roderick, Haupt, Riccardo, Kenney, Lisa B, Levine, Jennifer, van de Wetering, Marianne D, Tissing, Wim J E, Paul, Norbert W, Kremer, Leontien C M, and Inthorn, Julia

Published
2021
Full Text
View/download PDF

15. Fertility preservation for female patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group

Author

Berger, Claire, Diesch, Tamara, Dirksen, Uta, Ginsberg, Jill, Giwercman, Aleksander, Grabow, Desiree, Gracia, Clarisa, Hunter, Sarah E, Inthorn, Julia, Kaatsch, Peter, Kelvin, Joanne F, Klosky, James L, Laven, Joop S E, Lockart, Barbara A, Neggers, Sebastian JCMM, Paul, Norbert W, Peate, Michelle, Phillips, Bob, Reed, Damon R, Tinner, Eva Maria E, van den Berg, Marleen, Verhaak, Chris, Mulder, Renée L, Font-Gonzalez, Anna, Hudson, Melissa M, van Santen, Hanneke M, Loeffen, Erik A H, Burns, Karen C, Quinn, Gwendolyn P, van Dulmen-den Broeder, Eline, Byrne, Julianne, Haupt, Riccardo, Wallace, W Hamish, van den Heuvel-Eibrink, Marry M, Anazodo, Antoinette, Anderson, Richard A, Barnbrock, Anke, Beck, Joern D, Bos, Annelies M E, Demeestere, Isabelle, Denzer, Christian, Di Iorgi, Natascia, Hoefgen, Holly R, Kebudi, Rejin, Lambalk, Cornelis, Langer, Thorsten, Meacham, Lillian R, Rodriguez-Wallberg, Kenny, Stern, Catharyn, Stutz-Grunder, Eveline, van Dorp, Wendy, Veening, Margreet, Veldkamp, Saskia, van der Meulen, Eline, Constine, Louis S, Kenney, Lisa B, van de Wetering, Marianne D, Kremer, Leontien C M, Levine, Jennifer, and Tissing, Wim J E

Published
2021
Full Text
View/download PDF

16. Fertility preservation for male patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group

Author

Berger, Claire, Diesch, Tamara, Giwercman, Aleksander, Grabow, Desiree, Gracia, Clarisa, Hunter, Sarah E, Inthorn, Julia, Kaatsch, Peter, Kelvin, Joanne F, Klosky, James L, Laven, Joop S E, Lockart, Barbara A, Neggers, Sebastian JCMM, Paul, Norbert W, Peate, Michelle, Phillips, Bob, Quinn, Gwendolyn P, Reed, Damon R, Tinner, Eva Maria E, van den Berg, Marleen, Verhaak, Chris, Mulder, Renée L, Font-Gonzalez, Anna, Green, Daniel M, Loeffen, Erik A H, Hudson, Melissa M, Loonen, Jacqueline, Yu, Richard, Ginsberg, Jill P, Mitchell, Rod T, Byrne, Julianne, Skinner, Roderick, Anazodo, Antoinette, Constine, Louis S, de Vries, Andrica, Jahnukainen, Kirsi, Lorenzo, Armando, Meissner, Andreas, Nahata, Leena, Dinkelman-Smit, Marij, Tournaye, Herman, Haupt, Riccardo, van den Heuvel-Eibrink, Marry M, van Santen, Hanneke M, van Pelt, Ans M M, Dirksen, Uta, den Hartogh, Jaap, van Dulmen-den Broeder, Eline, Wallace, W Hamish, Levine, Jennifer, Tissing, Wim J E, Kremer, Leontien C M, Kenney, Lisa B, and van de Wetering, Marianne D

Published
2021
Full Text
View/download PDF

19. The Australian New Zealand Consortium in Children, Adolescents, and Young Adults Oncofertility action plan.

Author

Lau, Lei Shong, Allingham, Catherine, Anazodo, Antoinette, Sullivan, Michael, Peate, Michelle, Hunter, Sarah, Stern, Catharyn, Ryan, Anne Louise, Super, Leanne, Orme, Lisa M., McCarthy, Maria, Gook, Debra, Lewin, Jeremy, Marino, Jennifer, Ryan, Jessica, Downie, Peter, Manudhane, Rebecca, Winstanley, Mark, Pettit, Tristan, and Lantsberg, Daniel

Published
2024
Full Text
View/download PDF

21. Ovarian tissue cryopreservation as standard of care: what does this mean for pediatric populations?

Author

Nahata, Leena, Woodruff, Teresa K., Quinn, Gwendolyn P., Meacham, Lillian R., Chen, Diane, Appiah, Leslie C., Finlayson, Courtney, Orwig, Kyle E., Laronda, Monica M., Rowell, Erin E., Anazodo, Antoinette, Frias, Olivia, Rios, Julie Sroga, Whiteside, Stacy, Gomez-Lobo, Veronica, Dwiggins, Maggie, Childress, Krista J., Hoefgen, Holly R., Levine, Jennifer M., Jayasinghe, Yasmin, and Moravek, Molly

Published
2020
Full Text
View/download PDF

23. Development of a Pediatric Fertility Preservation Program: A Report From the Pediatric Initiative Network of the Oncofertility Consortium

Author

Moravek, Molly B., Appiah, Leslie C., Anazodo, Antoinette, Burns, Karen C., Gomez-Lobo, Veronica, Hoefgen, Holly R., Jaworek Frias, Olivia, Laronda, Monica M., Levine, Jennifer, Meacham, Lillian R., Pavone, Mary Ellen, Quinn, Gwendolyn P., Rowell, Erin E., Strine, Andrew C., Woodruff, Teresa K., and Nahata, Leena

Published
2019
Full Text
View/download PDF

24. A minority of women of childbearing potential are tested for pregnancy before chemoimmunotherapy: an Australian cancer centre experience.

Author

Chadwick, Verity, Kim, Michaela, Mills, Georgia, Tang, Catherine, Anazodo, Antoinette, Dear, Rachel, Rodgers, Rachael, Lavee, Orly, Milliken, Sam, McCaughan, Georgia, and Hamad, Nada

Subjects
CHILDBEARING age, WOMEN, PREGNANCY tests, IMMUNOTHERAPY, EARLY detection of cancer, DESCRIPTIVE statistics, CHI-squared test, CANCER chemotherapy, MINORITIES, DATA analysis software
Abstract

Background: Chemotherapy is potentially harmful to a developing foetus, and there are limited data on the foetal impact of chemoimmunotherapy (CIT). Therefore, determining pregnancy status prior to initiation of CIT should be standard of care. Aims: To determine how many women of childbearing age are tested for pregnancy prior to immunochemotherapy administration. Methods: A retrospective chart review at a large Australian metropolitan cancer referral centre, including 304 women aged 18–51 years with a diagnosis of cancer receiving outpatient‐based CIT between 1 May 2015 and 12 June 2020. We assessed the uptake of pregnancy screening and contraception counselling prior to and during first‐line CIT. Results: Only 17.3% of CIT cycles (n = 416) screened patients for pregnancy no more than 90 days prior to administration, and the median time between pregnancy screening and treatment was approximately 3 weeks. One patient with early breast cancer had a spontaneous miscarriage estimated at 3–4 weeks' gestation, and neither the patient nor the treating oncologist was aware of this event. This was also the only patient who had a pregnancy test beyond the first cycle of CIT during their treatment. Conclusions: Our results highlight a concerningly low rate of pregnancy screening in women of childbearing age receiving CIT. The implication of missing a positive pregnancy test in this group of women could result in foetal complications, accidental miscarriage, potential bleeding risks and avoidable psychosocial stress. This highlights the urgent need for guidelines to mandate pregnancy testing in women of childbearing age receiving CIT and evidence‐based implementation tools. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

25. Testicular function after non‐cytotoxic and immunotherapy drug treatment.

Author

Handelsman, David J., Idan, Amanda, Sleiman, Sue, Bacha, Fey, Long, Georgina V., Menzies, Alexander M., Vaishnav, Tejnei, Litkouhi, Noosha, Volckmar, Xanthie, Ledger, William, and Anazodo, Antoinette

Subjects
TESTIS physiology, IMMUNOTHERAPY, IMMUNE checkpoint inhibitors, FOLLICLE-stimulating hormone, CANCER treatment, CRYOPROTECTIVE agents
Abstract

Background: The effects of novel non‐cytotoxic and immunotherapy drugs for cancer treatment on human testicular function have not been studied systematically. Objectives: The present study aimed to characterize effects of non‐cytotoxic and immunotherapy drugs in patients with cancers who had not been previously treated with gonadotoxic chemo‐ or radiotherapy. Materials and methods: This study involved 34 men, not previously treated with gonadotoxic regimens, in a mixed longitudinal (Cohort 1: 19 men about to start and approximately 1 year on non‐cytotoxic and immunotherapy treatment) and cross‐sectional (Cohort 2: 15 men already on non‐cytotoxic and immunotherapy treatment) study using data modeling to estimate within‐person time‐course changes in testicular exocrine and endocrine functions. Cohort 1 provided 45 paired semen and blood samples (34 prior to and nine during treatment) and Cohort 2 provided 45 sets of samples (15 pre‐treatment, 30 on treatment), including six men in Cohort 2 who had pre‐treatment spermatozoa cryostorage prior to the study. Men on non‐cytotoxic and immunotherapy treatment had undergone a median of 33.5 months long‐term treatment. Results: Spermatozoa output and concentration were reduced by about 50%, with corresponding increases in serum follicle‐stimulating hormone and decreases in serum inhibin B. Serum testosterone, luteinizing hormone, and sex hormone‐binding globulin were unaffected by non‐cytotoxic and immunotherapy treatment. Conclusion: Within limits of the present study of sample size and duration of on‐non‐cytotoxic and immunotherapy treatment, non‐cytotoxic and immunotherapy drugs have a modest effects on testicular exocrine function (sperm production) or its hormonal correlates (follicle‐stimulating hormone, inhibin B), with minimal impact on testicular endocrine (testosterone, luteinizing hormone) function. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

26. Pregnancy‐associated gynecological cancer in New South Wales, Australia 1994–2013: A population‐based historical cohort study.

Author

Fotheringham, Penelope, Safi, Nadom, Li, Zhouyang, Anazodo, Antoinette, Remond, Marc, Hayen, Andrew, Currow, David, Roder, David, Hamad, Nada, Nicholl, Michael, Gordon, Adrienne, Frawley, Jane, and Sullivan, Elizabeth A.

Subjects
GENITAL warts, HUMAN papillomavirus vaccines, COHORT analysis, PREMATURE labor, FALLOPIAN tubes, ODDS ratio
Abstract

Introduction: Pregnancy‐associated gynecological cancer (PAGC) refers to cancers of the ovary, uterus, fallopian tube, cervix, vagina, and vulva diagnosed during pregnancy or within 12 months postpartum. We aimed to describe the incidence of, and perinatal outcomes associated with, invasive pregnancy‐associated gynecological cancer. Material and methods: We conducted a population‐based historical cohort study using linked data from New South Wales, Australia. We included all women who gave birth between 1994 and 2013, with a follow‐up period extending to September 30, 2018. Three groups were analyzed: a gestational PAGC group (women diagnosed during pregnancy), a postpartum PAGC group (women diagnosed within 1 year of giving birth), and a control group (women with control diagnosis during pregnancy or within 1 year of giving birth). We used generalized estimation equations to compare perinatal outcomes between study groups. Results: There were 1 786 137 deliveries during the study period; 70 women were diagnosed with gestational PAGC and 191 with postpartum PAGC. The incidence of PAGC was 14.6/100 000 deliveries and did not change during the study period. Women with gestational PAGC (adjusted odds ratio [aAOR] 6.81, 95% confidence interval [CI] 2.97–15.62) and with postpartum PAGC (aOR 2.65, 95% CI 1.25–5.61) had significantly increased odds of a severe maternal morbidity outcome compared with the control group. Babies born to women with gestational PAGC were more likely to be born preterm (aOR 3.11, 95% CI 1.47–6.59) and were at increased odds of severe neonatal complications (aOR 3.47, 95% CI 1.45–8.31) compared with babies born to women without PAC. Conclusions: The incidence of PAGC has not increased over time perhaps reflecting, in part, the effectiveness of cervical screening and early impacts of human papillomavirus vaccination programs in Australia. The higher rate of preterm birth among the gestational PAGC group is associated with adverse outcomes in babies born to these women. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

27. A minority of women of childbearing potential are tested for pregnancy before chemoimmunotherapy: an Australian cancer centre experience

Author

Chadwick, Verity, primary, Kim, Michaela, additional, Mills, Georgia, additional, Tang, Catherine, additional, Anazodo, Antoinette, additional, Dear, Rachel, additional, Rodgers, Rachael, additional, Lavee, Orly, additional, Milliken, Sam, additional, McCaughan, Georgia, additional, and Hamad, Nada, additional

Published
2023
Full Text
View/download PDF

28. Testicular function after non‐cytotoxic and immunotherapy drug treatment

Author

Handelsman, David J., primary, Idan, Amanda, additional, Sleiman, Sue, additional, Bacha, Fey, additional, Long, Georgina V., additional, Menzies, Alexander M., additional, Vaishnav, Tejnei, additional, Litkouhi, Noosha, additional, Volckmar, Xanthie, additional, Ledger, William, additional, and Anazodo, Antoinette, additional

Published
2023
Full Text
View/download PDF

35. "Queer people are excellent caregivers, but we're stretched so very thin": Psychosocial wellbeing and impacts of caregiving among LGBTQI cancer carers.

Author

Allison, Kimberley, Power, Rosalie, Ussher, Jane M., Perz, Janette, the Out with Cancer Study Team, Hawkey, Alexandra, Parton, Chloe, Watson, Lucy, Hickey, Martha, Dowsett, Gary W., Anazodo, Antoinette, Boydell, Katherine, Bruce, Jenni, Gilmore, Tenley, Ryan, Sam, and Ellis, Colin

Subjects
LGBTQ+ people, FAMILY support, WELL-being, LGBTQ+ communities, CAREGIVERS, ONCOLOGY nursing, DISCRIMINATION in medical care
Abstract

Background: LGBTQI (lesbian, gay, bisexual, transgender, queer and/or intersex) communities are increasingly recognized as a vulnerable and high-risk population in oncology. LGBTQI cancer carers, including carers who are LGBTQI and other carers of LGBTQI people, experience many of the same stressors as LGBTQI patients but their support needs are often overlooked in the cancer literature. Method: This mixed-methods study examined distress and quality of life in LGBTQI cancer carers. Online surveys were completed by 129 carers and 31 carers took part in a one-to-one semi-structured interview. Analyses of variance (ANOVAs) tested for differences in psychosocial outcomes and carer experiences by gender, sexuality, age, carer relationship and carer/patient LGBTQI status. Reflexive thematic analysis of interviews and open-ended survey responses facilitated in-depth examination of subjective experiences. Results: 42.6% of participants reported high or very high distress. Distress was significantly positively correlated with discrimination in cancer care, health impact, financial impact and lack of family support; it was negatively correlated with comfort in LGBTQI sexuality and gender identity, social support and quality of life. Four themes were identified in thematic analysis of qualitative data: (1) Identity on the sidelines: LGBTQI sexuality and gender pushed aside during cancer caregiving; (2) Fear of being shut-out: rejection and exclusion of LGBTQI cancer carers; (3) Lack of support for LGBTQI caregivers; and (4) Closer and stronger relationships due to a culture of mutual caregiving. Conclusions: LGBTQI cancer carers must contend with typical caregiving demands whilst also managing additional minority stressors, including discrimination, rejection from family, isolation from LGBTQI communities, and invisibility in healthcare and support services. Despite this, LGBTQI carers showed resilience in building their own mutually supportive networks to rally around the person with cancer, which were reported to ameliorate psychosocial vulnerabilities. Service providers need to recognize the needs of LGBTQI cancer carers through inclusive and reflective practices. This will facilitate trust and patient and carer sexuality and gender identity disclosure, with positive consequences for wellbeing and satisfaction with cancer care. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

38. Beyond Medical Care: How Different National Models of Care Impact the Experience of Adolescent and Young Adult Cancer Patients

Author

Patterson, Pandora, primary, Jacobsen, Rebecca L., additional, McDonald, Fiona E.J., additional, Pflugeisen, Chaya M., additional, Bibby, Kit, additional, Macpherson, Catherine Fiona, additional, Thompson, Kate, additional, Murnane, Andrew, additional, Anazodo, Antoinette, additional, Sansom-Daly, Ursula M., additional, Osborn, Michael P., additional, Hayward, Allan, additional, Kok, Cindy, additional, and Johnson, Rebecca H., additional

Published
2023
Full Text
View/download PDF

39. Adapting the Voicing My CHOiCES Advance Care Planning Communication Guide for Australian Adolescents and Young Adults with Cancer: Appropriateness, Acceptability, and Considerations for Clinical Practice

Author

Sansom-Daly, Ursula M., primary, Zhang, Megan, additional, Evans, Holly E., additional, McLoone, Jordana, additional, Wiener, Lori, additional, Cohn, Richard J., additional, Anazodo, Antoinette, additional, Patterson, Pandora, additional, and Wakefield, Claire E., additional

Published
2023
Full Text
View/download PDF

40. Rates of Menstrual History-Taking and Counseling With Anticancer Treatments Are Low: People Who Menstruate Deserve Gender-Specific Cancer Care

Author

Chadwick, Verity, primary, Kim, Michaela, additional, Mills, Georgia, additional, Tang, Catherine, additional, Anazodo, Antoinette, additional, Dear, Rachel, additional, Rodgers, Rachael, additional, Lavee, Orly, additional, Milliken, Samuel, additional, McCaughan, Georgia, additional, Moore, John, additional, Withers, Barbara, additional, and Hamad, Nada, additional

Published
2023
Full Text
View/download PDF

41. Successful treatment of acute lymphoblastic leukemia (ALL) during pregnancy using a pediatric-based protocol incorporating pegylated asparaginase.

Author

Jeffrey, Anthony, Presgrave, Peter, Walsh, Colin A., Sinn, John, Kennedy, Debra, Anazodo, Antoinette, Kumar, Poomahal, Osborn, Michael, Trahair, Toby, Bradstock, Kenneth, Dalla-Pozza, Luciano, and Greenwood, Matthew

Subjects
LYMPHOBLASTIC leukemia, ASPARAGINASE, ACUTE leukemia, MEDICAL personnel, TREATMENT effectiveness
Abstract

This article discusses a case study of a pregnant woman diagnosed with acute lymphoblastic leukemia (ALL) during her second trimester. The woman was enrolled in a clinical trial that allowed pregnant patients to participate. She received treatment based on a pediatric protocol that included the use of pegylated asparaginase. The patient achieved complete remission and delivered a healthy baby. The case highlights the challenges of managing maternal and fetal risks during ALL therapy and emphasizes the need for collaboration between healthcare professionals to optimize outcomes. Further research is needed to confirm the safety of pegylated asparaginase in pregnancy. [Extracted from the article]

Published
2023
Full Text
View/download PDF

42. Pregnancy‐associated gynecological cancer in New South Wales, Australia 1994–2013: A population‐based historical cohort study

Author

Fotheringham, Penelope, primary, Safi, Nadom, additional, Li, Zhouyang, additional, Anazodo, Antoinette, additional, Remond, Marc, additional, Hayen, Andrew, additional, Currow, David, additional, Roder, David, additional, Hamad, Nada, additional, Nicholl, Michael, additional, Gordon, Adrienne, additional, Frawley, Jane, additional, and Sullivan, Elizabeth A., additional

Published
2023
Full Text
View/download PDF

45. Australian fertility preservation guidelines for people with cancer 2022: review and recommendations

Author

Kieu, Violet, primary, Stern, Catharyn, additional, Harris, Jessica, additional, Jayasinghe, Yasmin, additional, Bradford, Natalie, additional, Cui, Wanyuan, additional, Deans, Rebecca, additional, Hunter, Tamara, additional, Allingham, Catherine, additional, Kane, Stefan C, additional, Lau, Lei Shong, additional, Logan, Shanna, additional, McLachlan, Robert, additional, Neville, Kristen, additional, Peate, Michelle, additional, Phillips, Marianne, additional, Saunders, Carla, additional, Tome, Marianne, additional, Upreti, Rita, additional, White, Kate, additional, Anazodo, Antoinette, additional, and Hart, Roger J, additional

Published
2022
Full Text
View/download PDF

46. Selective Intra-Arterial Doxorubicin Eluting Microsphere Embolization for Desmoid Fibromatosis: A Combined Prospective and Retrospective Study

Author

Elnekave, Eldad, primary, Ben Ami, Eytan, additional, Shamai, Sivan, additional, Peretz, Idit, additional, Tamir, Shlomit, additional, Bruckheimer, Elchanan, additional, Stemmer, Amos, additional, Erinjeri, Joseph, additional, Abu Quider, Abed, additional, Seidensticker, Max, additional, Wildgruber, Moritz, additional, Ricke, Jens, additional, Anazodo, Antoinette, additional, Fung, Kin Fen, additional, Zer, Alona, additional, and Ash, Shifra, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results